Washington Post: “Pains, chills, fatigue, vomiting and vertigo plague me. Small fiber neuropathy causes it all.”
This Washington Post article proves the value of definitive small fiber neuropathy testing.
According to the patient, who authored the article, the biopsy results “proved my neurologist was right.” The neurologist is a Therapath client: Teena Shetty, MD, with Hospital for Special Surgery in New York City.
Related Articles
New Study Examines Fixative Solutions Used in Skin Biopsy Test for Small Fiber Neuropathy
Therapath LLC finalized a comparison study of the most common fixation methods used in Epidermal Nerve Fiber Density testing for the determination of SFN. [Read More]
Therapath Neuropathology Announces National Ophthalmic Pathology Program
Therapath LLC, a leader in neuropathology laboratory services, launches its national ophthalmic pathology program. [Read More]
Research Finds Nerve Damage in Patients with Fibromyalgia
Therapath, LLC reports that new findings have revealed that patients diagnosed with fibromyalgia may also have a diagnosable small fiber neuropathy. [Read More]
Quality of Life and Usefulness of Skin Biopsy in Small Fiber Neuropathy (SFN)
Bakkers et al examined a total of 265 patients diagnosed with small fiber neuropathy (SFN). They found that SFN was associated with a severe impairment in Quality of Life...[Read More]
New Upper Extremity Standard Biopsy Sites for Diagnosis of Small Fiber Neuropathy
Therapath LLC has established normative values for two upper limb body sites that can now be used to evaluate 3mm punch skin biopsy specimens...[Read More]
Washington Post: “Pains, chills, fatigue, vomiting and vertigo plague me. Small fiber neuropathy causes it all.”
This Washington Post article proves the value of definitive small fiber neuropathy testing.
According to the patient, who authored the article, the biopsy results “proved my neurologist was right.” The neurologist is a Therapath client: Teena Shetty, MD, with Hospital for Special Surgery in New York City.
Related Articles
New Study Examines Fixative Solutions Used in Skin Biopsy Test for Small Fiber Neuropathy
Therapath LLC finalized a comparison study of the most common fixation methods used in Epidermal Nerve Fiber Density testing for the determination of SFN. [Read More]
Therapath Neuropathology Announces National Ophthalmic Pathology Program
Therapath LLC, a leader in neuropathology laboratory services, launches its national ophthalmic pathology program. [Read More]
Research Finds Nerve Damage in Patients with Fibromyalgia
Therapath, LLC reports that new findings have revealed that patients diagnosed with fibromyalgia may also have a diagnosable small fiber neuropathy. [Read More]
Quality of Life and Usefulness of Skin Biopsy in Small Fiber Neuropathy (SFN)
Bakkers et al examined a total of 265 patients diagnosed with small fiber neuropathy (SFN). They found that SFN was associated with a severe impairment in Quality of Life...[Read More]
New Upper Extremity Standard Biopsy Sites for Diagnosis of Small Fiber Neuropathy
Therapath LLC has established normative values for two upper limb body sites that can now be used to evaluate 3mm punch skin biopsy specimens...[Read More]
